West Virginia University Cancer Institute is West Virginia’s premier cancer facility with a national reputation of excellence in cancer treatment, prevention and research. The Scientific Programs within the MBRCC are organized to nurture interactions between basic, clinical and population scientists and are designed to impact on specific health disparities and populations with unique needs within our state.Read More
Dennis Slamon, M.D., Ph.D., an internationally renowned physician scientist whose work led to the development of the breast cancer drug Herceptin, will deliver the 2016 Laurence and Jean DeLynn Lecture at 4 p.m., September 7, in the Fukushima Auditorium of the of the West Virginia University Health Sciences Center. A reception will follow in the Learning Center Commons.
Nearly 200 healthcare professionals from Morgantown and the surrounding region took advantage of the 2nd Annual WVU Cancer Institute Breast Cancer Conference: From Mammograms to Metastatic Breast Cancer held recently at Erickson Alumni Center in Morgantown. Several who attended the continuing education event were from the Cancer Institute’s regional affiliates at Berkeley Medical Center in Martinsburg, Camden Clark Medical Center in Parkersburg and Garrett Regional Medical Center in Oakland, MD. Bonnie’s Bus Director Sara Jane Gainor and WVU Cancer Institute Director of Clinical Services Hannah Hazard, MD, shared various aspects of the conference with WBOY TV.